Peter Campbell

Peter is the CSO and one of the academic cofounders of Quotient. 

Until January 2025, he continues to serve as the Head of Cancer, Aging and Somatic Mutation at the Wellcome Sanger Institute where his research program focuses on the genetic changes cells acquire throughout life, and how these mutations are related to aging, cancer and other disease processes.

His research focuses on cancer genomics, and in particular genome-wide analyses of somatic mutations in tumors. Outside of cancer, his focus areas include how somatic mutations delineate clonal relationships of normal cellular populations and how somatic mutations affect normal cellular behavior.

Peter received his PhD from the University of Cambridge and completed his postdoctoral fellowship at the Wellcome Sanger Institute.